With companies paying substantial sums for marketing rights over deuterated drugs, Michael Furrow and Erin Austin examine critical patent strategies and considerations.
October 01, 2019
September 30, 2019
August 21, 2019
October 27 - 30, 2019
November 19, 2019 Venable LLP